No doubt there's great value here.
IMO the reason not many are buying is simply because of the opportunity cost. Biotechs are in a downtrend and IBX trial results could still be another few months away. In the meantime I could jump on Copper, Lithium, Uranium etc stocks to make additional % before buying back into IBX.
